These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7863014)

  • 1. On the significance of cholecystokinin receptors in panic disorder.
    van Megen HJ; den Boer JA; Westenberg HG
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):1235-46. PubMed ID: 7863014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin and panic disorder: past and future clinical research strategies.
    Bradwejn J; Koszycki D
    Scand J Clin Lab Invest Suppl; 2001; 234():19-27. PubMed ID: 11713976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is cholecystokinin a biological support in panic attacks?].
    Bourin M; Bradwejn J; Koszycki D
    Encephale; 1991; 17(5):475-9. PubMed ID: 1686250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cholecystokinin hypothesis of anxiety and panic disorder.
    Bradwejn J; Koszycki D
    Ann N Y Acad Sci; 1994 Mar; 713():273-82. PubMed ID: 8185169
    [No Abstract]   [Full Text] [Related]  

  • 5. Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses.
    Abelson JL; Nesse RM
    Biol Psychiatry; 1994 Jul; 36(2):73-83. PubMed ID: 7948449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats.
    Bertoglio LJ; Zangrossi H
    Brain Res; 2005 Oct; 1059(1):46-51. PubMed ID: 16168394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilatory effects of cholecystokinin: new role for an old peptide?
    Ruiz-Gayo M; González MC; Fernández-Alfonso S
    Regul Pept; 2006 Dec; 137(3):179-84. PubMed ID: 16889840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCK in anxiety and cognitive processes.
    Daugé V; Léna I
    Neurosci Biobehav Rev; 1998 Oct; 22(6):815-25. PubMed ID: 9809313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptides and anxiety: focus on cholecystokinin.
    Lydiard RB
    Clin Chem; 1994 Feb; 40(2):315-8. PubMed ID: 8313613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.
    Zwanzger P; Domschke K; Bradwejn J
    Depress Anxiety; 2012 Sep; 29(9):762-74. PubMed ID: 22553078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin induces cerebral vasodilatation via presynaptic CCK2 receptors: new implications for the pathophysiology of panic.
    Sánchez-Fernández C; González C; Mercer LD; Beart PM; Ruiz-Gayo M; Fernández-Alfonso MS
    J Cereb Blood Flow Metab; 2003 Mar; 23(3):364-70. PubMed ID: 12621311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder.
    Pande AC; Greiner M; Adams JB; Lydiard RB; Pierce MW
    Biol Psychiatry; 1999 Sep; 46(6):860-2. PubMed ID: 10494457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin and panic disorder--three unsettled questions.
    Rehfeld JF
    Regul Pept; 2000 Sep; 93(1-3):79-83. PubMed ID: 11033055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects.
    Lydiard RB; Ballenger JC; Laraia MT; Fossey MD; Beinfeld MC
    Am J Psychiatry; 1992 May; 149(5):691-3. PubMed ID: 1575262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurobiological investigations into the role of cholecystokinin in panic disorder.
    Bradwejn J
    J Psychiatry Neurosci; 1993 Jul; 18(4):178-88. PubMed ID: 8104032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [From inducers of panic attack to neurobiology of panic disorder].
    Bourin M
    Encephale; 1996 Dec; 22 Spec No 5():35-41. PubMed ID: 9138945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic environmental intolerance: increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7.
    Binkley K; King N; Poonai N; Seeman P; Ulpian C; Kennedy J
    J Allergy Clin Immunol; 2001 May; 107(5):887-90. PubMed ID: 11344357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CCK-system mediates adaptation to novelty-induced stress in the rat: a pharmacological evidence.
    Ballaz SJ; Akil H; Watson SJ
    Neurosci Lett; 2007 Nov; 428(1):27-32. PubMed ID: 17950531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholecystokinin antagonists: anxiolytic drugs of the future].
    Bourin M; Bradwejn J
    Pathol Biol (Paris); 1992 Mar; 40(3):215-7. PubMed ID: 1608663
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological actions of cholecystokinin.
    Crawley JN; Corwin RL
    Peptides; 1994; 15(4):731-55. PubMed ID: 7937354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.